SUMMARY The value of three agents in reducing the area of myocardial ischemia in rabbit hearts perfused with crystalloid solution was examined. Ten hearts received crystalloid solution with methylprednisolone (M), 0.25 mg/ml; 18 with hyaluronidase (H), 4 U/mi; and 10 with propranolol (P), 1 g.g/ml.
LIMITING myocardial necrosis during an evolving myocardial infarction is of major clinical significance because the extent of damage after coronary artery occlusion is a strong determinant of patient survival." 2 Numerous studies have investigated the character, extent and reversibility of myocardial ischemic injury, but the nature of the transition from reversible to irreversible damage remains obscure. The continuum of metabolic, biophysical and electrophysiologic changes between the center of an ischemic area and the adjacent normal tissue provides a conceptual framework for the presence of a critical oxygen-diffusion zone in tissue. 3 We defined this zone as the area of unperfused, but not anoxic, tissue surrounding a myocardial infarction. Effective therapy of a border zone might salvage a substantial volume of reversibly injured myocardial tissue. Many histochemical,4 metabolic,56 and radio isotopic7 techniques have been used to measure this border zone. The reported widths are highly dependent on the measurement technique and have varied from 2 to 15 mm. 8 Infarct size can be influenced by pharmacologic intervention, but numerous studies of similar agents have produced conflicting results. Further, not only are the therapies controversial, but also the methods used to evaluate them have been disputed because of the inability to accurately differentiate ischemic from normoxic myocardium.
In this study, we used nicotinamide adenine dinucleotide (NADH) fluorophotography9 to evaluate the influence of three pharmacologic agents on limiting infarct size. Hyaluronidase, an oxygen-diffusion facilitator; methylprednisolone, a steroidal antiinflammatory agent; and propranolol, an agent for reducing oxygen demand, were administered after acute coronary ligation in the isolated, perfused rabbit heart.
Methods and Materials
Seventy-four New Zealand rabbits that weighed 2 Forty minutes after ligation, each heart was perfused with rhodamine. As soon as the dye emerged from the pulmonary artery catheter (2-3 seconds), the heart was quick-frozen between large metal tongs and plunged into liquid nitrogen.'0 After the heart was completely frozen, the epicardium was trimmed to a depth of 0.5 mm to remove the epicardial vessels and surface ice, and NADH fluorophotographs were taken. The heart was then removed from the aluminum block and weighed.
The photographs were enlarged x 15 and the area not perfused with rhodamine and the anoxic zone of NADH fluorescence were digitized by computer. In addition, the distance between rhodamine and NADH florescence was measured at 20 Discussion The ability to modify myocardial infarct size is an important clinical goal. The delineation of a periischemic oxygen-diffusion zone has stimulated efforts directed at saving it and thereby reducing infarct size.9 Methods of quantitating the extent of myocardial ischemia suffer from a lack of spatial resolution and discrimination between ischemic and normoxic myocardium.
In this study, we exploited the ability of NADH fluorophotography to locate areas of cellular anoxia. wall tension were not examined in this study. We have no explanation for the observed and reproducible decrease in MVOJ.
Our results demonstrate that methylprednisolone increases in total coronary flow (p < 0.001) and coronary sinus Po, (p < 0.5). Unlike hyaluronidase, methylprednisolone did not change MV02 (p > 0.1). The epicardial ischemic area was reduced compared with postligation control (p < 0.05). Our results confirm previous reports that steroids permit an increase in coronary flow,26 27 perhaps by preventing the endothelial swelling associated with ischemia.2t 29 This increase in coronary flow and the increase in capillary oxygen tension without a corresponding increase in myocardial oxygen demand allow oxygen to diffuse farther into the ischemic zone. This was documented by an increase in the oxygen-diffusion zone (p < 0.001). Since the anoxic area was encroached upon by an increased oxygen gradient, there was also a decrease in the ratio of the anoxic to the nonperfused area (p < 0.001).
The major criticism of using steroids to treat acute myocardial infarction is their deleterious effect on the healing process.3"3' Other studies33 34 have shown that hydrocortisone (2-10 mg/kg daily) had no significant effect on healing 2-60 days after acute experimental coronary arterial ligation.
Our finding that propranolol failed to reduce the extent of epicardial or transmural ischemia requires further consideration. None of the variables examined demonstrated an advantageous effect on the ischemic myocardium or on the oxygen-diffusion zone. Propranolol can salvage reversibly damaged myocardial tissue in vivo.35"-" In our model, the hearts were neurohormonally isolated, the heart rate was fixed and the ventricles did not generate pressure. Therefore, decreasing MVO, in the face of maximal catecholamine output would be of no benefit in our preparation. We did verify observations that propranolol does not increase collateral flow to ischemic myocardium. We could not corroborate evidence that propranolol may provide protection for the ischemic myocardium by mechanisms other than its 13-blocking activity and myocardial oxygen balance. 38 39 I
